KKR, a leading global investment firm, today announced the final closing of KKR Health Care Strategic Growth Fund II (“HCSG II” or the “Fund”), a $4.0 billion fund dedicated to health care growth equity investment opportunities primarily in North America and Europe. With a diversified portfolio approach, HCSG II will focus on the biopharmaceutical, medical device, health care services, life science tools / diagnostics, and health care information technology sub-sectors.
Read the full article: KKR Closes $4B Health Care Strategic Growth Fund II //
Source: https://www.businesswire.com/news/home/20220110005267/en/KKR-Closes-4.0-Billion-Health-Care-Strategic-Growth-Fund-II